NCT00080392View on ClinicalTrials.gov

EW-A-401 to Treat Intermittent Claudication

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 27, 2004

Study Completion Date

December 29, 2011

Conditions
Intermittent ClaudicationArteriosclerosis
Interventions
DRUG

DNA Plasmid Vector

DRUG

EW-A-401 DNA Plasmid Vector

Trial Locations (3)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

35213

Baptist Health System, Inc., Birmingham

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00080392 - EW-A-401 to Treat Intermittent Claudication | Biotech Hunter | Biotech Hunter